Please try another search
Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA – PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.
Name | Age | Since | Title |
---|---|---|---|
Dedi Segal | 47 | - | Founder & CEO & Director |
Asi Rotbert | 48 | - | Chief Business Officer & Director |
Markus Veit | 65 | 2019 | Scientific Advisor |
David Meiri | - | - | Scientific Advisor |
Aaron Ciechanover | 77 | 2019 | Scientific Advisor |
Michal Sapir | 67 | 2022 | Independent External Director |
Rinat Gazit | 55 | - | Independent Director |
Deir Noa Leibovich | - | - | Scientific Advisor |
Moshe Reuveni | 68 | - | Independent External Director |
Michal Marom-Brikman | 55 | - | Independent External Director |
Tal Yaron Eldar | 61 | - | Director |
Michal Dadon-Yagil | 54 | - | Independent External Director |
Essie Rothbert | 49 | - | Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review